全文获取类型
收费全文 | 7262篇 |
免费 | 710篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 399篇 |
妇产科学 | 141篇 |
基础医学 | 951篇 |
口腔科学 | 57篇 |
临床医学 | 738篇 |
内科学 | 1452篇 |
皮肤病学 | 172篇 |
神经病学 | 575篇 |
特种医学 | 312篇 |
外科学 | 1240篇 |
综合类 | 212篇 |
一般理论 | 2篇 |
预防医学 | 574篇 |
眼科学 | 144篇 |
药学 | 465篇 |
2篇 | |
中国医学 | 6篇 |
肿瘤学 | 470篇 |
出版年
2022年 | 40篇 |
2021年 | 105篇 |
2020年 | 80篇 |
2019年 | 122篇 |
2018年 | 138篇 |
2017年 | 105篇 |
2016年 | 98篇 |
2015年 | 137篇 |
2014年 | 188篇 |
2013年 | 237篇 |
2012年 | 341篇 |
2011年 | 378篇 |
2010年 | 228篇 |
2009年 | 179篇 |
2008年 | 356篇 |
2007年 | 333篇 |
2006年 | 337篇 |
2005年 | 359篇 |
2004年 | 317篇 |
2003年 | 295篇 |
2002年 | 283篇 |
2001年 | 223篇 |
2000年 | 240篇 |
1999年 | 177篇 |
1998年 | 81篇 |
1997年 | 79篇 |
1996年 | 104篇 |
1995年 | 93篇 |
1994年 | 62篇 |
1993年 | 85篇 |
1992年 | 172篇 |
1991年 | 172篇 |
1990年 | 143篇 |
1989年 | 125篇 |
1988年 | 126篇 |
1987年 | 131篇 |
1986年 | 106篇 |
1985年 | 131篇 |
1984年 | 85篇 |
1983年 | 82篇 |
1982年 | 59篇 |
1981年 | 42篇 |
1979年 | 58篇 |
1978年 | 43篇 |
1977年 | 51篇 |
1976年 | 51篇 |
1975年 | 51篇 |
1974年 | 42篇 |
1973年 | 40篇 |
1971年 | 44篇 |
排序方式: 共有7989条查询结果,搜索用时 15 毫秒
91.
Abstract: We report the first case of fatal anthrax meningoencephalitis in Hong Kong over the past 60 years. A 13 year-old boy presented with right lower quadrant pain, diarrhoea and progressive headache. Lumbar puncture yielded gram positive bacilli initially thought to be Bacillus cereus, a contaminant. He was treated with ampicillin and cefotaxime, but died 3 days after hospitalization. The organism isolated from blood and cerebrospinal fluid was later identified as Bacillus anthracis. 相似文献
92.
38所综合医院病种质量管理调查分析 总被引:7,自引:1,他引:7
搜集整理吉林省 38所二、三级综合医院为期一年的 31个病种3.4万份病例的信息资料,对其治疗转归、平均住院日和平均住院费用进行了统计分析,为制定病种质量控制标准和深入广泛开展病种质量管理提供了可靠依据。 相似文献
93.
A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma 总被引:8,自引:2,他引:8
Chen J; Giovannucci E; Hankinson SE; Ma J; Willett WC; Spiegelman D; Kelsey KT; Hunter DJ 《Carcinogenesis》1998,19(12):2129-2132
We examined the relationship between a functional polymorphism (667C--
>T, ala-->val) of the methylenetetrahydrofolate reductase gene
(MTHFR) and the risk of colorectal adenomas in the prospective Nurses'
Health Study. Among 257 incident polyp cases and 713 controls, the MTHFR
val/val polymorphism [relative risk (RR) = 1.35, 95% confidence interval
(CI) 0.84-2.17] was not significantly associated with risk of adenomas.
This lack of association was observed for both small (RR = 1.36, 95% CI
0.76-2.45) and large (RR = 1.32, 95% CI 0.66-2.66) adenomas. Furthermore,
there was no significant interaction between this polymorphism and
consumption of either folate, methionine or alcohol. We also examined the
relationship of a newly identified polymorphism (asp919gly) of the
methionine synthase gene (MS) with the risk of colorectal adenomas in the
same population. The MS gly/gly polymorphism was also not significantly
associated with risk of colorectal adenomas (RR = 0.66, 95% CI 0.26-1.70).
These results, which need to be confirmed in other studies, suggest that
the MTHFR val/val polymorphism, which has been previously inversely
associated with risk of colorectal cancer, plays a role only in a late
stage (adenoma-- >carcinoma) of colorectal tumorigenesis, and/or may
protect against malignant transformation in the subset of benign adenomas,
which may progress to malignancy.
相似文献
94.
BACKGROUND: There is evidence that the stage of illness at which antipsychotic treatment is initiated in schizophrenia may have consequences for its subsequent course. How this might relate to impaired adaptive life functioning in the long-term is poorly understood. METHODS: Thirty-eight inpatients, many of whom had been admitted in the preneuroleptic era, were assessed using the Social-Adaptive Functioning Evaluation (SAFE); constituent clinical and medication phases of the lifetime trajectory of their illnesses were then analyzed to identify predictors of SAFE score using multiple regression modeling. RESULTS: The primary, independent predictor of SAFE score was duration of initially unmedicated psychosis, which accounted for 22% of variance (p<.001) therein. Conversely, duration of subsequently treated illness, although decades longer, failed to predict SAFE score. CONCLUSIONS: These findings are consistent with some form of "progressive" process, particularly over the first several years following the emergence of psychosis, which is associated with accrual of deficits in adaptive life functioning. 相似文献
95.
96.
97.
98.
99.
Bennett CL Stinson TJ Lane D Amylon M Land VJ Laver JH 《Medical and pediatric oncology》2000,34(2):92-96
BACKGROUND: Growth factor use has been shown to ameliorate chemotherapy-induced neutropenia, leading to shorter hospital stays and lower use of parenteral antibiotics, two costly areas of cancer treatment. Prior reports on pediatric patients have shown evidence of cost savings in some studies, but no such evidence in others. In this study a retrospective analysis compared the costs of inpatient supportive care for pediatric patients with T-cell leukemia and advanced lymphoblastic lymphoma enrolled in a Pediatric Oncology Group trial. PROCEDURE: Patients 1-22 years of age were randomized to receive either granulocyte colony-stimulating factor (G-CSF; n = 45) or no G-CSF (n = 43) following induction and two cycles of maintenance therapy. There were no significant differences in neutropenia-related outcomes during the induction phase. During maintenance therapy, G-CSF patients had significantly fewer days to an ANC >500 cells/microl and a trend towards fewer days of hospitalization. Data on resource utilization were tabulated from case report forms. Costs were imputed from national data on hospitalization costs, average wholesale prices of pharmaceuticals, and patient billing information from a single institution. RESULTS: Total median costs of supportive care were $34,190 for patients receiving G-CSF and $28,653 for patients not receiving G-CSF (P > 0. 05 for the cost difference). Sensitivity analyses demonstrated that the total cost difference was not statistically significant, even in scenarios that included reasonable variations in estimates of the range of the length of stay, antibiotic regimen, and dosage and cost of G-CSF. CONCLUSIONS: In the setting of pediatric leukemia, the cost of growth factor may offset potential savings from shorter hospital stays or lower antibiotic use, a finding consistent with that from the Children's Cancer Study Group. 相似文献
100.
背景和目的:罗格列酮与阿伐他汀联合疗法已经被证实对于2型糖尿病患者的血糖控制以及脂质水平都有益处。本试验将通过检测罗格列酮与阿伐他汀联合疗法对于2型糖尿病患者的生物标记水平的作用来研究该联合疗法对血管炎的作用。方法:30例患有2型糖尿病和高脂血症的患者被纳入治疗。对这些患者给予罗格列酮单一疗法4mg/d,持续3个月,然后在接下来的3个月中给予这些患者阿伐他汀10mg/d作为联合疗法。在研究开始时,罗格列酮单一疗法之后以及罗格列酮与阿伐他汀联合治疗之后测量炎性生物标记物,包括高敏C-反应蛋白(hs-CRP)、基质金属蛋白酶9(MMP… 相似文献